c



    c 



GBI Research¶s report, ³In-vitro and Companion Diagnostics Industry- 2010 Yearbook´
provides key data, information and analysis on the global invitro diagnostic and companion
  market. The report provides a market landscape, competitive landscape and market
trends information on the following market categories: clinical chemistry, immunochemistry,
hematology, histology and cytology, microbiology, infectious immunology, genetic testing and
companion diagnostics. The report provides comprehensive information on the key trends
affecting the aforementioned categories, and key analytical content on the market dynamics. The
report also reviews the latest, advances in in-vitro diagnostics technology. This report is built
using data and information sourced from proprietary databases, primary and secondary research
and in-house analysis by GBI Research¶s team of industry experts.



Its scope includes:

- Market revenue data from 2002 to 2009. Forecast revenue data to 2016. Company shares data
for 2009.
- Market size and company share data for six diagnostic imaging market categories: clinical
chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious
immunology, genetic testing and companion diagnostics.
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain and
Japan.
- Qualitative analysis of the key market trends, and market drivers and restraints, by each
category within the diagnostic imaging market.
- The report also covers information on the leading market players, the competitive landscape,
and the leading technologies.
- Key players covered include F.Hoffman-La Roche, Abbott Laboratories, bioMerieux, Beckman
Coulter, Qiagen, Dako Denmark A/S, Siemens Medical Solutions.


  

1 Table of Contents 4
1.1 List of Tables 8
1.2 List of Figures 10
2 Global IVD and CDx Market: Introduction and Overview 12
2.1 In-vitro and Companion diagnostics 12
2.1.1 Overview 12
2.2 GBI Research Report Guidance 13
3 Global IVD and CDx Market: Market Characterization 14
3.1 Global IVD and CDx Market, Revenues ($m), 2002±2009 14
3.2 Global IVD and CDx Market, Revenue Forecasts ($m), 2009±2016 16
3.3 Global IVD and CDx Market, Key Company Shares (%), 2009 18
3.4 Global IVD and CDx Market: Key Market Trends 19
3.4.1 Entry of Diagnostic Imaging Players Into In Vitro Diagnostics Market has Set the Stage for
New Technologies to be Developed by Marrying the Two Disciplines 19
3.4.2 Large Number of Private Equity/Venture Capital (PE/VC) Investments and Collaborations
in the IVD Sector will Fuel Innovation 20
3.4.3 Consolidation of Laboratories across the World 20
3.5 Global IVD and CDx Market: Key Technology Trends 21
3.5.1 Emerging Technologies for Cutting Laboratory Costs 21
3.5.2 New Technologies Improve Speed and Accuracy 22
3.6 Global IVD and CDx Market: Market Drivers 23
3.6.1 Economic Market Drivers 23
3.6.2 Technology Market Drivers 25
3.6.3 Regulatory Market Drivers 25
3.6.4 Social Market Drivers 26
3.7 Global IVD and CDx Market: Market Restraints 26
3.7.1 Economic Market Restraints 26
3.7.2 Social Market Restraints 27
4 Global IVD and CDx Market: Market Category Analysis and Forecasts 28
4.1 Clinical Chemistry Market: Market Characterization 28
4.1.1 Global Clinical Chemistry Market, Revenues ($m), 2002±2009 28
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009±2016 30
4.1.3 Global Clinical Chemistry Market, Key Company Shares (%), 2009 32
4.1.4 Clinical Chemistry Market: Market Drivers 33
4.1.5 Clinical Chemistry Market: Market Restraints 34
4.2 Immuno Chemistry Market: Market Characterization 36
4.2.1 Global Immuno Chemistry Market, Revenues ($m), 2002±2009 36
4.2.2 Global Immuno Chemistry Market, Revenue Forecasts ($m), 2009±2016 38
4.2.3 Global Immuno Chemistry Market, Key Company Shares (%), 2009 40
4.2.4 Immuno Chemistry Market: Market Drivers 42
4.2.5 Immuno Chemistry Market: Market Restraints 44
4.3 Hematology Market: Market Characterization 45
4.3.1 Global Hematology Market, Revenues ($m), 2002±2009 45
4.3.2 Global Hematology Market, Revenue Forecasts ($m), 2009±2016 47
4.3.3 Global Hematology Market, Key Company Shares (%), 2009 49
4.3.4 Hematology Market: Market Drivers 50
4.3.5 Hematology Market: Market Restraints 51
4.4 Histology and Cytology Market: Market Characterization 52
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002±2009 52
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009±2016 53
4.4.3 Global Histology and Cytology Market, Key Company Shares (%), 2009 54
4.4.4 Histology and Cytology Market: Market Drivers 55
4.4.5 Histology and Cytology Market: Market Restraints 56
4.5 Microbiology Culture Market: Market Characterization 57
4.5.1 Global Microbiology Culture Market, Revenues ($m), 2002±2009 57
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009±2016 59
4.5.3 Global Microbiology Culture Market, Key Company Shares (%), 2009 61
4.5.4 Global Microbiology Culture Market: Market Drivers 62
4.5.5 Global Microbiology Culture Market: Market Restraints 63
4.6 Infectious Immunology Market: Market Characterization 64
4.6.1 Global Infectious Immunology Market, Revenues ($m), 2002±2009 64
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009±2016 65
4.6.3 Global Infectious Immunology Market, Key Company Shares (%), 2009 66
4.6.4 Global Infectious Immunology Market: Market Drivers 67
4.6.5 Global Infectious Immunology Market: Market Restraints 68
4.7 Genetic Testing Market: Market Characterization 69
4.7.1 Global Genetic Testing Market, Revenues ($m), 2002±2009 69
4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009±2016 70
4.7.3 Global Genetic Testing Market, Key Company Shares (%), 2009 71
4.7.4 Global Genetic Testing Market: Market Drivers 72
4.7.5 Global Genetic Testing Market: Market Restraints 73
4.8 Global Companion Diagnostics Market: Market Characterization 74
4.8.1 Introduction 74
4.8.2 Selected Companion Diagnostic Assays/Kits 77
4.8.3 Applications of Companion Diagnostics 80
4.8.4 Global Companion Diagnostics Market, Revenue Forecasts ($m), 2009±2016 82
4.8.5 Global Companion Diagnostics Market, Oncology, Revenue Forecasts ($m), 2009-2016 83
4.8.6 Global Companion Diagnostics Market, Infectious Diseases, Revenue Forecasts ($m),
2009-2016 85
4.8.7 Global Companion Diagnostics Market, Cardiovascular Diseases, Revenue Forecasts ($m),
2009-2016 87
4.8.8 Global Companion Diagnostics Market, 2010 88
4.8.9 Global Companion Diagnostics Market: Market Drivers 89
4.8.10 Global Companion Diagnostics Market: Market Restraints 89
5 Global IVD and CDx Market: Country Analysis and Forecasts 91
5.1 Global IVD Market: Geographic Trends Analysis 91
5.2 Market Characterization, the US, 2002±2016 92
5.2.1 The US IVD and CDx Market, Revenues ($m), 2002±2009 92
5.2.2 The US IVD and CDx Market, Revenues ($m), 2009±2016 94
5.2.3 The US IVD and CDx Market, Market Drivers 95
5.2.4 The US IVD and CDx Market, Market Restraints 95
5.3 Market Characterization, Europe, 2002±2016 96
5.3.1 The UK IVD and CDx Market 96
5.3.2 The UK IVD and CDx Market, Revenues ($m), 2009±2016 97
5.3.3 Germany IVD and CDx Market, Revenues ($m), 2002±2009 99
5.3.4 Germany IVD and CDx Market, Revenues ($m), 2009±2016 101
5.3.5 France IVD and CDx Market, Revenues ($m), 2002±2009 103
5.3.6 France IVD and CDx Market, Revenues ($m), 2009±2016 105
5.3.7 Italy IVD and CDx Market, Revenues ($m), 2002±2009 107
5.3.8 Italy IVD and CDx Market, Revenues ($m), 2009 ± 2016 109
5.3.9 Spain IVD and CDx Market, Revenues ($m), 2002±2009 111
5.3.10 Spain IVD and CDx Market, Revenues ($m), 2009±2016 113
5.3.11 Europe IVD and CDx Market, Market Drivers 114
5.3.12 Europe IVD and CDx Market, Market Restraints 115
5.4 Market Characterization, Japan, 2002±2016 116
5.4.1 Japan IVD and CDx Market, Revenues ($m), 2002±2009 116
5.4.2 Japan IVD and CDx Market, Revenues ($m), 2009±2016 118
5.4.3 Japan IVD and CDx Market, Market Drivers 119
5.4.4 Japan IVD and CDx Market, Market Restraints 120

4  

!!"""##!!c



 
 
c 



$%%%# 

&'

Offshore Rig Construction Market to 2015 - Premium Jack-up Segment Witnessing High Growth
Despite Massive Supplies During the Rig Construction Boom
Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and
Increasing Population of Critically Ill Patients To Drive Growth
Computed Tomography (CT) Systems Market to 2016 - The High Slice Segment to be the Key
Revenue Generator
X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver
Geothermal Power Market in Americas to 2020 - High Potential along with Favorable Policies
Propelling The US Market
Healthcare System and Delivery Network ± 2010 Yearbook
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost
Effectiveness Will Accelerate the Number of Clinical Trials